Moon S. Choi
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2026
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.
Journal: Annals of hepatology
Published: November 15, 2025
Safety and Efficacy of Combining Metastasis-Directed Stereotactic Ablative Radiation Therapy with Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors in Metastatic Hepatocellular Carcinoma.
Journal: Cancer research and treatment
Published: September 05, 2025
Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 12, 2025
Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge.
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Published: October 29, 2024
A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease.
Journal: Journal of gastroenterology and hepatology
Published: October 15, 2024
Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess.
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Published: October 11, 2024
Serum Ferritin Levels and Liver-Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study.
Journal: Alimentary pharmacology & therapeutics
Published: October 01, 2024
Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC.
Journal: JHEP reports : innovation in hepatology
Published: June 07, 2024
Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma.
Journal: Journal of Korean medical science
Published: May 22, 2024
Last Updated: 09/26/2026